[1]¶­ÈÙÄÈ,À.È˹¤ÖÇÄÜÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÕï¶ÏÖÐÓ¦ÓõÄÑо¿½øÕ¹[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2020,40(06):412-415.[doi:10.3760/cma.j.cn121383-20200328-03075]
¡¡Dong Rongna,Li Jing.Advances in the application of artificial intelligence in the diagnosis of diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2020,40(06):412-415.[doi:10.3760/cma.j.cn121383-20200328-03075]
µã»÷¸´ÖÆ

È˹¤ÖÇÄÜÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÕï¶ÏÖÐÓ¦ÓõÄÑо¿½øÕ¹()
·ÖÏíµ½£º

¡¶¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾¡·[ISSN:1673-4157/CN:12-1383/R]

¾í:
40
ÆÚÊý:
2020Äê06ÆÚ
Ò³Âë:
412-415
À¸Ä¿:
×ÛÊö
³ö°æÈÕÆÚ:
2020-11-20

ÎÄÕÂÐÅÏ¢/Info

Title:
Advances in the application of artificial intelligence in the diagnosis of diabetic retinopathy
×÷Õß:
¶­ÈÙÄÈÀ
Ìì½òÒ½¿Æ´óѧÖìÏÜÒͼÍÄîÒ½ÔºÄÚ·ÖÃÚ¿Æ,Ìì½òÊÐÄÚ·ÖÃÚÑо¿Ëù,ÎÀÉú½¡¿µÎ¯¼¤ËØÓë·¢ÓýÖصãʵÑéÊÒ,Ìì½òÊдúлÐÔ¼²²¡ÖصãʵÑéÊÒ 300134
Author(s):
Dong Rongna Li Jing
Department of Endocrinology, Laboratory of Hormones and Development,Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China
¹Ø¼ü´Ê:
È˹¤ÖÇÄÜ ÌÇÄò²¡ÊÓÍøĤ²¡±ä ÌÇÄò²¡
Keywords:
Artificial intelligence Diabetic retinopathy Diabetes mellitus
DOI:
10.3760/cma.j.cn121383-20200328-03075
ÎÄÏ×±êÖ¾Âë:
A
ÕªÒª:
È˹¤ÖÇÄÜÒѾ­³ÉΪ¼ÆËã»úÑо¿ÁìÓòµÄÈȵã,²¢¿ªÊ¼Ó¦ÓÃÓÚÒ½ÁƱ£½¡ÁìÓò,ÆäÔÚ¼õÉÙÈ˹¤¸ºµ£¡¢ÖÊÁ¿±£Ö¤ºÍ¿É¼°ÐÔ·½ÃæÓÅÊÆÏÔÖø¡£ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÔçÆÚÕï¶Ï,¶ÔÔ¤·À¼²²¡µÄ½øÕ¹ÓÐÖØÒªµÄÒâÒå,ÒòΪÑÛ¿ÆҽʦÊýÁ¿Ô¶Ô¶Âú×ã²»ÁËÕï¶ÏµÄÐèÇó,±ã´ßÉúÁËÈ˹¤ÖÇÄܼ¼ÊõÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÕï¶Ï·½ÃæµÄ»ý¼«Ó¦Ó᣽üÄêÀ´È˹¤ÖÇÄܼ¼ÊõÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÕï¶ÏÖеÄÓ¦ÓÃ,ΪÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÔçÆÚÕï¶ÏÌṩÁËеÄ˼·¡£
Abstract:
Artificial intelligence(AI)has emerged as a hot field in computer science research. Healthcare affordability, quality, and accessibility can be amplified by using this technology. Early diagnosis of diabetic retinopathy is very important for the prevention of diabetic retinopathy. There is a significant disparity in the number of ophthalmologists and the need for diagnosis, which leads to the active application of artificial intelligence technology in the diagnosis of diabetic retinopathy. The application of artificial intelligence technology in the diagnosis of diabetic retinopathy in recent years, provides a new way for the early diagnosis of diabetic retinopathy.

²Î¿¼ÎÄÏ×/References:

[1] Hamet P, Tremblay J. Artificial intelligence in medicine[J].Metabolism,2017,69S:S36-S40.DOI:10.1016/j.metabol.2017.01.011.
[2] Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare:past, present and future[J].Stroke Vasc Neurol, 2017,2(2):230-243.DOI:10.1136/svn-2017-000101.
[3] ÑîÁá,Éòçô. ÌÇÄò²¡ÐÔÊÓÍøĤ²¡±äÓë¸ÉÑÛµÄÏà¹ØÐÔÑо¿[J]. ¹ú¼ÊÑÛ¿ÆÔÓÖ¾, 2018, 18(4):744-747.DOI:10.3980/j.issn.1672-5123.2018.4.39.
[4] Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs[J].JAMA,2016,316(22):2402-2410.DOI:10.1001/jama.2016.17216.
[5] Xu Y,Wang Y,Liu B, et al.The diagnostic accuracy of an intelligent and automated fundus disease image assessment system with lesion quantitative function(SmartEye)in diabetic patients [J].BMC Ophthalmol,2019,19(1):184.DOI:10.1186/s12886-019-1196-9.
[6] Hill BL,Brown R,Gabel E,et al. An automated machine learning-based model predicts postoperative mortality using readily-extractable preoperative electronic health record data[J].Br J Anaesth,2019,123(6):877-886.DOI:10.1016/j.bja.2019.07.030.
[7] Suzuki K. Overview of deep learning in medical imaging[J].Radiol Phys Technol,2017,10(3):257-273.DOI: 10.1007/s12194-017-0406-5.
[8] Murchison AP, Hark L, Pizzi LT,et al. Non-adherence to eye care in people with diabetes[J].BMJ Open Diabetes Res Care,2017,5(1):e000333.DOI:10.1136/bmjdrc-2016-000333.
[9] ÁºÊææÃ,²ÅÒÕ,°×ÏòÀö,µÈ.±±¾©ÊеÂʤÉçÇøÌÇÄò²¡ÊÓÍøĤ²¡±äÔ¶³Ìɸ²éϵͳµÄÓ¦ÓÃ[J].ÖлªÊµÑéÑÛ¿ÆÔÓÖ¾,2018,36(1):40-45.DOI:10.3760/cma.j.issn.2095-0160.2018.01.009.
[10] Gargeya R,Leng T. Automated identification of diabetic retinopathy using deep learning[J].Ophthalmology,2017,124(7):962-969.DOI:10.1016/j.ophtha.2017.02.008.
[11] US Food and Drug Administration. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems.2018.Available from:https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357.htm.Published April 11.
[12] Wong LY, Acharya R, Venkatesh YV, et al. Identification of different stages of diabetic retinopathy using retinal optical images[J].Inf Sci,2008,178(1):106-121.DOI:10.1016/j.ins.2007.07.020.
[13] Yazid H, Arof H, Isa HM. Automated identification of exudates and optic disc based on inverse surface thresholding[J].J Med Syst,2012,36(3):1997-2004.DOI:10.1007/s10916-011-9659-4.
[14] Akyol K, ÿðþ ‰C en B, Bay¢cr ÿðþ ‰C . Automatic detection of optic disc in retinal image by using keypoint detection, texture analysis, and visual dictionary techniques[J].Comput Math Methods Med,2016,2016:6814791.DOI:10.1155/2016/6814791.
[15] Yan Q,Zhao Y,Zheng Y, et al. Automated retinal lesion detection via image saliency analysis[J].Med Phys,2019,46(10):4531-4544.DOI:10.1002/mp.13746.
[16] Rajalakshmi R, Subashini R, Anjana RM, et al. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence[J].Eye(Lond),2018,32(6):1138-1144.DOI:10.1038/s41433-018-0064-9.
[17] Bhaskaranand M, Ramachandra C, Bhat S,et al. Automated diabetic retinopathy screening and monitoring using retinal fundus image analysis[J].J Diabetes Sci Technol,2016,10(2):254-261.DOI:10.1177/1932296816628546.
[18] Ting DSW,Cheung CY,Lim G,et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes[J].JAMA,2017,318(22):2211-2223.DOI:10.1001/jama.2017.18152.
[19] Abr¨¤moff MD,Lavin PT,Birch M, et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices[J].NPJ Digit Med,2018,1:39.DOI:10.1038/s41746-018-0040-6.
[20] Chan GCY,Kamble R,Muller H,et al. Fusing results of several deep learning architectures for automatic classification of normal and diabetic macular edema in optical coherence tomography[J].Annu Int Conf IEEE Eng Med Biol Soc,2018,2018:670-673.DOI:10.1109/EMBC.2018.8512371.
[21] Alsaih K, Lemaitre G, Rastgoo M, et al. Machine learning techniques for diabetic macular edema(DME)classification on SD-OCT images[J].Biomed Eng Online,2017,16(1):68.DOI:10.1186/s12938-017-0352-9.
[22] Gerendas BS, Bogunovic H, Sadeghipour A, et al. Computational image analysis for prognosis determination in DME[J].Vision Res,2017,139:204-210.DOI:10.1016/j.visres.2017.03.008.
[23] Hecht I,Bar A,Rokach L,et al. Optical coherence tomography biomarkers to distinguish diabetic macular edema from pseudophakic cystoid macular edema using machine learning algorithms[J].Retina,2019,39(12):2283-2291.DOI:10.1097/IAE.0000000000002342.
[24] De Fauw J, Ledsam JR, Romera-Paredes B, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease[J].Nat Med,2018,24(9):1342-1350.DOI:10.1038/s41591-018-0107-6.
[25] Kermany DS, Goldbaum M, Cai W, et al. Identifying medical diagnoses and treatable diseases by image-based deep learning[J]. Cell,2018,172(5):1122-1131.e9.DOI:10.1016/j.cell.2018.02.010.
[26] Prahs P, Radeck V, Mayer C, et al. OCT-based deep learning algorithm for the evaluation of treatment indication with anti-vascular endothelial growth factor medications[J]. Graefes Arch Clin Exp Ophthalmol,2018,256(1):91-98.DOI:10.1007/s00417-017-3839-y.
[27] Ô¬½ø.»ùÓÚÑÛµ×ÕÕÏàµÄÌÇÄò²¡ÊÓÍøĤ²¡±äÈ˹¤ÖÇÄÜɸ²éϵͳӦÓÃÖ¸ÄÏ[J].ÖлªÊµÑéÑÛ¿ÆÔÓÖ¾,2019,37(8):593-598.DOI:10.3760/cma.j.issn.2095-0160.2019.08.001.

ÏàËÆÎÄÏ×/References:

[1]ËÕÔÂ,Íõ½à,ÓÚ«˜.Ѫ½¬ÏËάµ°°×Ô­ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±ä »¼ÕßÖеÄˮƽ¼°ÒâÒå[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2016,36(01):1.[doi:10.3760/cma.j.issn.1673-4157.2016.01.001]
¡¡Su Yue,Wang Jie,Yu Pei..Level of plasma fibrinogen in patients with diabetic retinopathy and its significance[J].International Journal of Endocrinology and Metabolism,2016,36(06):1.[doi:10.3760/cma.j.issn.1673-4157.2016.01.001]
[2]ÒóÇÎ,ÕÅÔÆÁ¼,¹ùÊçÇÛ,µÈ.Êӻƴ¼½áºÏµ°°×4¡¢³¬ÃôC·´Ó¦µ°°× ÓëÌÇÄò²¡ÊÓÍøĤ²¡±äµÄ¹Øϵ[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
¡¡Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[3]¸ßè´,ÐÅÖÐ,Ô¬Ã÷ϼ,µÈ.´úл×ÛºÏÕ÷ÓëÌÇÄò²¡¼°ÌÇÄò²¡Ç°ÆÚÈËȺ ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÏà¹ØÐÔ·ÖÎö[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2017,37(05):298.
¡¡Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(06):298.
[4]ÁõÏþÄÝ ÍõÓ± ÀîÌÒÌÒ ÂíСÃô ÁºÑå.Ѫ¹Ü½ôÕÅËØת»»Ã¸»ùÒòrs4353¶à̬ÐÔ ÓëÌÇÄò²¡Î¢Ñª¹Ü²¡±äµÄÏà¹ØÐÔÑо¿[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2018,38(03):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
¡¡Liu Xiaoni*,Wang Ying,Li Taotao,et al.Association between angiotensin converting enzyme gene rs4353 polymorphism and diabetic microangiopathy[J].International Journal of Endocrinology and Metabolism,2018,38(06):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
[5]±Ï»áÀû ÕŻ۾ê.ÐźÅËØ3¼Ò×åÓëÌÇÄò²¡¼°Æä΢Ѫ¹Ü²¢·¢Ö¢[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2018,38(02):110.[doi:10.3760/cma.j.issn.1673-4157.2018.02.010]
¡¡Bi Huili,Zhang Huijuan..Class 3 semaphorins in diabetes mellitus and its microvascular complications[J].International Journal of Endocrinology and Metabolism,2018,38(06):110.[doi:10.3760/cma.j.issn.1673-4157.2018.02.010]
[6]ÕŲ© Àî·ï¾ý ×óÖзò.Éú³¤ÒÖËضÔÌÇÄò²¡´óÊóÊÓÍøĤ²¡±äµÄÉñ¾­ ±£»¤×÷Óü°¶ÔGFAP¡¢Í»´¥Ëرí´ïµÄÓ°Ïì[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2018,38(06):370.[doi:10.3760/cma.j.issn.1673-4157.2018.06.003]
¡¡Zhang Bo*,Li Fengjun,Zuo Zhongfu.The neuroprotection of somatostatin and its effects on the expression of GFAP and synaptophysin in rats with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2018,38(06):370.[doi:10.3760/cma.j.issn.1673-4157.2018.06.003]
[7]º«Ð㵤 ÖìÁèÑà Ðì»ýÐÖ.¶þ¼×Ë«ëÒ¶ÔÌÇÄò²¡ÊÓÍøĤ²¡±äµÄ×÷Óü°»úÖÆ[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2019,39(01):53.[doi:10.3760/cma.j.issn.1673-4157.2019.01.013]
¡¡Han Xiudan,Zhu Lingyan,Xu Jixiong.Effects of metformin on diabetic retinopathy and its mechanism[J].International Journal of Endocrinology and Metabolism,2019,39(06):53.[doi:10.3760/cma.j.issn.1673-4157.2019.01.013]
[8]Óá±ùºè Ñî¾Õºì µ¥´ºÑÞ.×èÈûÐÔ˯ÃߺôÎüÔÝÍ£µÍͨÆø×ÛºÏÕ÷ÓëÌÇÄò²¡ ÊÓÍøĤ²¡±äµÄ¹Øϵ[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2019,39(04):269.[doi:10.3760/cma.j.issn.1673-4157.2019.04.013]
¡¡Yu Binghong,Yang Juhong,Shan Chunyan.Relationship between obstructive sleep apnea syndrome and diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2019,39(06):269.[doi:10.3760/cma.j.issn.1673-4157.2019.04.013]
[9]Ëï÷ ÁõèòêÏ Íõ±ù ¸ßÕþÄÏ.ÎüÑÌÓëÖÐÀÏÄêÌÇÄò²¡»¼ÕßÊÓÍøĤ²¡±äµÄ Ïà¹ØÐÔÑо¿[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2020,40(04):223.[doi:10.3760/cma.j.issn.1673-4157.2020.04.002]
¡¡Sun Mei,Liu Xuhan,Wang Bing,et al.Study on the correlation between smoking and diabetic retinopathy in middle-age and old people[J].International Journal of Endocrinology and Metabolism,2020,40(06):223.[doi:10.3760/cma.j.issn.1673-4157.2020.04.002]
[10]»ÆÇìÏÈ,ºúÎij¬,ºÎÀ¼½Ü.ѪÇåasprosinÓëÌÇÄò²¡ÊÓÍøĤ²¡±äµÄ Ïà¹ØÐÔÑо¿[J].¹ú¼ÊÄÚ·ÖÃÚ´úлÔÓÖ¾,2020,40(06):372.[doi:10.3760/cma.j.cn121383-20200311-03027]
¡¡Huang Qingxian,Hu Wenchao,He Lanjie.Association of serum asprosin concentrations with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2020,40(06):372.[doi:10.3760/cma.j.cn121383-20200311-03027]

±¸×¢/Memo

±¸×¢/Memo:
»ù½ðÏîÄ¿:Ìì½òÊпƼ¼¼Æ»®ÏîÄ¿(18ZXZNSY00280); Ìì½òÊнÌίÉç»á¿ÆѧÖØ´óÏîÄ¿(2019JWZD54); Ìì½òÒ½¿Æ´óѧÖìÏÜÒͼÍÄîÒ½Ôº¿ÆÑлù½ð(2008DX02) ͨÐÅ×÷Õß:À,Email:2003-victor@163.com
¸üÐÂÈÕÆÚ/Last Update: 2020-11-20